iCAD IncICAD
About: icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
Employees: 69
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
9% more capital invested
Capital invested by funds: $7.45M [Q2] → $8.15M (+$701K) [Q3]
1.98% less ownership
Funds ownership: 21.58% [Q2] → 19.6% (-1.98%) [Q3]
10% less funds holding
Funds holding: 52 [Q2] → 47 (-5) [Q3]
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
78% less call options, than puts
Call options by funds: $8K | Put options by funds: $37K
Research analyst outlook
We haven’t received any recent analyst ratings for ICAD.
Financial journalist opinion
Based on 3 articles about ICAD published over the past 30 days